Position in FHTX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$449,424
-$21,288 QoQ
Shares Held
92,096
-6.5% QoQ
Ownership
0.155%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#30
of 102 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 40%
Shared 0%
None 60%
Common Shares in FHTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026MORGAN STANLEY holds $16,717,848,806 across 523 Biotechnology names. FHTX ranks #279 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
42,931,597 | $2,407,174,637 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,242,139 | $1,610,467,694 | |
| 3 | ROIV |
Roivant Sciences Ltd.
|
42,592,905 | $1,507,362,901 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,397,712 | $871,529,332 | |
| 5 | MRNA |
Moderna, Inc.
|
9,538,094 | $667,952,718 | |
| 6 | ARGX |
Argenx SE
|
643,123 | $596,670,219 | |
| 7 | TECH |
BIO-TECHNE Corp
|
6,374,717 | $450,373,747 | |
| 8 | INCY |
Incyte Corp
|
2,948,364 | $334,226,536 |
All Filings in FHTX
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $449,424 | 92,096 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $470,712 | 98,476 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $657,323 | 121,727 | Shares | Defined | 2026-05-27 | |
| 2025-09-30 | $311,372 | 63,676 | Shares | Defined | 2026-05-27 | |
| 2025-06-30 | $373,897 | 79,553 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 | $253,567 | 69,471 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $460,410 | 97,545 | Shares | Defined | 2025-05-15 | |
| 2024-09-30 | $1,007,348 | 108,201 | Shares | Defined | 2025-05-14 | |
| 2024-06-30 | $374,312 | 65,098 | Shares | Defined | 2025-05-14 | |
| 2024-03-31 | $503,046 | 74,970 | Shares | Defined | 2024-10-17 | |
| 2023-12-31 | $677,976 | 105,113 | Shares | Defined | 2024-08-16 | |
| 2023-09-30 | $361,235 | 72,247 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $622,108 | 88,368 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $580,113 | 93,567 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $1,923,989 | 301,566 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $8,889,864 | 1,036,115 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $16,611,880 | 1,221,462 | Shares | Defined | 2022-10-27 | |
| 2022-03-31 | $15,667,495 | 1,028,726 | Shares | Defined | 2022-10-27 | |
| 2021-12-31 | $12,622,064 | 551,905 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $13,640,629 | 979,227 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $10,458,827 | 980,209 | Shares | Defined | 2021-08-23 | |
| 2021-03-31 | $5,189,255 | 393,722 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $866,420 | 42,744 | Shares | Defined | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||